{"page_content": "2020 CORPORATE SOCIAL RESPONSIBILITY REPORT90\nDear Communities\nABOUT SERVE TRANSFORM ADVANCE REDEFINE ETHICS & COMPLIANCE REPORTING INDEX   MATERIAL TOPIC LOCATION BOUNDARY\nEthicsAlexion 2020 CSR Report, Ethics & Compliance: Our Foundation, Page 65 (Integrity Matters: Being \nTrue to Who We Are), Page 66 (Ethics and Business Conduct), Page 66 (Maintaining Our Culture of \nIntegrity), Page 67 (Integrity Matters Week)Internal/External\nExecutive Compensation Alexion 2020 Form 10-K/A, Item 11 (Executive Compensation) Primarily Internal\nGovernanceAlexion 2020 CSR Report, Ethics & Compliance: Our Foundation, Page 69 (Facilitating Exceptional \nCorporate Governance), Page 70 (Governing Our Political Activities)Internal/External\nAlexion 2020 Form 10-K/A, Item 10 (Directors, Executive Officers and Corporate Governance)\nHealth Outcomes &  \nPatient SafetyAlexion 2020 CSR Report, Transform Patient Lives, Page 34 (Communicating Safety and Efficacy), \nPage 35 (Product Safety), Page 35 (Advancing our High-Quality Standards)Primarily External\nManufacturing Alexion 2020 CSR Report, Transform Patient Lives, Page 35 (Advancing our High-Quality Standards) Internal\nOccupational Health Safety \nand WellnessAlexion 2020 CSR Report, Advance Our People and Our Company, Page 50 (Championing Brain \nHealth), Page 51 (Well-Rounded Well-Being), Page 52 (Prioritizing Occupational Health and Safety), \nPage 53 (Occupational Health and Safety Targets and Metrics) Internal\nPatient Organization \nEngagement Alexion 2020 CSR Report, Transform Patient Lives, Page 31 (Collaborating with Patient Organizations) Internal/External\nPhysician Awareness and \nEducationAlexion 2020 CSR Report, Transform Patient Lives, Page 28 (Accelerating Results for Patients),  \nPage 31 (Collaborating with Patient Organizations), Page 34 (Communicating Safety and Efficacy)External\nPricing and ReimbursementAlexion 2020 Form 10-K, Item 1 (Business: Pharmaceutical Pricing and Reimbursement); Item 1A \n(Risk Factors: Risks Related to Pricing and Reimbursement)Internal/External\nProduct Disposition Alexion 2020 Form 10-K, Item 1A (Risk Factors: Risks Related to Business Operations) Internal/External\nResearch & DevelopmentAlexion 2020 CSR Report, Redefine Living With a Rare Disease or Devastating Condition, Page 58  \n(Advancing Revolutionary Diagnostics), Page 59 (Innovative Medicines)Internal/External\nWebsite: Research and Development\nSupply ChainAlexion 2020 CSR Report, Ethics & Compliance: Our Foundation, Page 72 (Holding Our Suppliers to \nHigh Standards)Internal/ExternalDISCLOSURE 103-1 AND 103-2: MANAGEMENT APPROACH (CONTINUED)", "metadata": {"source": "NASDAQ_ALXN_2020.pdf", "page": 89, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}